Mar 20 |
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
|
Mar 20 |
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
|
Mar 20 |
Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's Why
|
Mar 19 |
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
|
Mar 19 |
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
|
Mar 18 |
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
|
Mar 18 |
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
|
Mar 18 |
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a Bet
|
Mar 18 |
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
|
Mar 18 |
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
|